• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recallsee related information
Date Initiated by FirmMay 28, 2004
Date PostedJuly 20, 2004
Recall Status1 Terminated 3 on November 23, 2004
Recall NumberZ-1039-04
Recall Event ID 29292
Product Classification Dna-Reagents, Cytomegalovirus - Product Code LSO
ProductDigene Hybrid Capture System CMV DNA Test (version 2.0), packaged in a cardboard box containing test reagents for performing 60 tests. Digene Catalog #4403-2003.
Code Information Lot number 6234, EXP 10/20/04
FEI Number 3003572099
Recalling Firm/
Manufacturer
Digene Corp
1201 Clopper Rd
Gaithersburg MD 20878-4000
For Additional Information ContactDonna Sowers
301-944-7007
Manufacturer Reason
for Recall
In vitro diagnostic test kit may produce false negative clinical results.
FDA Determined
Cause 2
Other
ActionThe recalling firm notified consignees by phone 5/28/04 and by faxed letter 6/2/04. The letter advised of possible false negative test results and that such results should be retested immediately with replacement kits provided by the firm. The notification further advised that positive results should be considered valid if the assay meets all verification and calibration criteria. Consignees were requested to return product and response form.
Quantity in Commerce206 kits
DistributionProduct was sold to medical facility clinical laboratories nationwide and a distributor in the United Kingdom.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-